Homeopathy 2021; 110(03): 147-148
DOI: 10.1055/s-0041-1731450
Editorial

A Bar Set Attainably High

Robert T. Mathie
1  Homeopathy Research Institute, London, United Kingdom
› Author Affiliations

Fifty-seven individuals contributed at least one peer-review report for the journal in 2020. These individuals' names are listed and acknowledged in the February 2021 issue.[1] The rigorous assessment of submitted manuscripts is key to the quality of any academic journal, and Homeopathy is no exception to that rule. I've sometimes heard it said, “It's easy to get an article published in Homeopathy”—that conclusion would be as ill-judged today as it has always been! The editorial and peer-review standards at this journal are set at a high level, as affirmed for example in the rate of rejection of papers, whose average has been 60% over the past 8 years. Thus, looking solely at Original Research and Review articles during that 8-year period (and excluding ineligible manuscripts on non-homeopathy topics), out of a total of 432 submissions up to May 1st, 2021, 171 have been accepted and 261 rejected. The confidential peer-review reports that the editor has the pleasure to solicit and to follow-up are invariably written with perceptive insight, thorough objective analysis and constructive unbiased commentary, along with a clear and a well-justified recommendation of “Accept”, “Revise” or “Reject”. For a developing science like homeopathy, it's appropriate that an evidently good-quality piece of research, but whose first submission falls somewhat below the necessary standard of write-up, deserves to be given the opportunity for essential revision: the authors of such an article benefit from the reviewers' and the editor's comments. With its strict standards yet encouraging demeanour, Homeopathy therefore helps to nurture new or young researchers in developing their research and writing expertise, as well as being an attractive vehicle of research dissemination for more experienced authors. With the “Accept bar” set at a high but attainable level, the journal benefits from a position as an authoritative literature source.

The five Original Research articles in this issue range from a randomized controlled trial on cutaneous warts,[2] a clinical observational study aimed at improving homeopathic prescribing in coronavirus disease 2019 (COVID-19),[3] a cross-sectional study of patients undergoing treatment at cancer centres in Strasbourg, France,[4] and an in-vitro investigation into the cytoprotective effects of the homeopathic remedy CANOVA against cell death induced by the anti-malarial drug artesunate,[5] to the validation of a chromatographic method for the standardization of homeopathic Syzygium cumini.[6] A Clinical Case Series and a Case Report article both illustrate the improvement in symptoms that can accrue from a well-selected individualized homeopathic medicine.[7] [8] And we have four Debate items on matters of topical significance: one of them contains a summary of COVID-19 research initiatives in India,[9] and another proposes Antimonium tartaricum as genus epidemicus medicine for the coronavirus disease.[10] A profound philosophical approach, with practical consequences, is the keynote for the remaining two Debate articles, which consider respectively the Principle of Similars[11] and the contribution of mixed-methods research[12] for a deeper appreciation and understanding of homeopathy.



Publication History

Publication Date:
27 July 2021 (online)

© 2021. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany